Market Currents

• Tuesday, December 22, 2009

• 10:23 AM Winners in the Senate healthcare reform:
  - Drug and device makers (PFE, MRK, BSX, MDT)
  - Hospitals (UHS, THC)
  - Biologics (AMGN)
  - Cosmetics (JNJ, AGN)
  - Home healthcare providers (AMED, ADUS, GTIV)
  Losers:
  - Health insurers (WLP, UNH, AET)
  - Generic drugmakers
  - Pharmacy benefit managers (MHS, CVS, ESRX)
  - Nursing homes (SKH, KND) 2 Comments

• Tuesday, October 20, 2009

• 09:00 AM Premarket gainers: MPS +22%. BPAX +11%. LXK +9%. IRE +8%. AAPL +6%. NVAX +5%. CAT +6%. UAUA +6%. MGM +5%. HGSI +5%. UNH +4%. BK +5%. PH +5%. AIB +4%. PSO +4%. BTU +4%.
  Losers: MI -8%. FRE -7%. BSX -7%. Comment!

• Monday, October 19, 2009

• 17:42 PM Boston Scientific (BSX): Q3 EPS of $0.19 beats by $0.05. Revenue of $2.03B (+3%) vs. $2.04B. Sees Q4 EPS of $0.17-0.21 vs. $0.17. Expects full-year adjusted EPS of $0.75-0.79 vs. $0.56. Shares +0.9% AH. (PR) Comment!
• 00:10 AM Notable post-market earnings: AAPL, ATHR, BSX, JDAS, LNCR, PKG, STLD, TXN, UDR, VLTR, WERN, ZION Comment!

• Tuesday, October 6, 2009

• 09:48 AM Drugmakers, hospitals and laboratories are emerging as the winners in the latest version of the Obama administration's healthcare program, being voted on in the Senate this week. Potential losers include device makers, who will be forced to pay $4B/year under Rep. Baucus' plan. BSX -1.2%. MDT -2.7%. Comment!
• 09:00 AM Premarket gainers: AVCT +21%. HL +6%. SLW +5%. GBG +5%. GSS +5%. MPG +4%. AUY +4%. IVN +4%. RTK +4%. NGD +4%. CIT +4%. ALU +4%.
  Losers: STJ -13%. CVM -10%. BSX -4%. MDT -4%. Comment!

• Tuesday, September 29, 2009

• 17:11 PM Boston Scientific (BSX) will pay Johnson & Johnson (JNJ) $716M to settle a dozen patent lawsuits, including the Palmaz-NIR stent suit. (PR) Comment!

• Monday, July 20, 2009

• 17:38 PM Boston Scientific (BSX): Q2 adjusted EPS of $0.20 beats by $0.07. Revenue of $2.1B (-2.4%) vs. $2B. Sees Q3 EPS of $0.17-0.21 vs. $0.15 and Q3 revenue of $2B-2.1B vs. $2B. Sees FY09 EPS of $0.82-0.86 vs. $0.57 and FY09 revenue of $8.1B-8.4B vs. $8.2B. Shares +5.3% AH. (PR) Comment!
• 00:10 AM Notable earnings after Monday's close: BSX, CNI, LM, MDRX, PKG, SY, TXN, WERN, ZION Comment!

• Thursday, June 25, 2009

• 13:33 PM Boston Scientific (BSX) +7.8% after the "sudden and surprising" resignation of CEO Jim Tobin, to be replaced by former Zimmer CEO Ray Elliot (PR). Analysts say the change is likely to be positive for the stock, given Elliot's track record. And Tobin's. He helped orchestrate BSX's $27.5B purchase of Guidant in 2006, which Fortune dubbed the "second-worst deal ever." Comment!

• Tuesday, June 23, 2009

• 10:26 AM Boston Scientific (BSX) +6% early on after a large-scale study finds its heart implants slowed the progression of heart failure when implanted early - which could widen the target market substantially. Comment!
• 09:00 AM Premarket gainers: ALVR +15%. PCS +9%. BSX +8%. ETFC +7%. UBS +6%. MTL +5%. OCNF +5%. AAUK +5%. STJ +4%. CENX +4%. CF +4%. ACAS +4%.
  Losers: RMBS -10%. HALO -9%. CTIC -5%. Comment!

• Sunday, May 17, 2009

• 09:39 AM Though Medtronic (MDT) has lost market share to rivals Boston Scientific (BSX) and Abbott Laboratories (ABT), the company deserves more credit for recent transformations, writes Barron's Neil A. Martin. Shares could rise 25-30% in the next year. Comment!

• Tuesday, April 21, 2009

• 06:56 AM Boston Scientific (BSX): Q1 EPS of $0.19 beats by $0.07. Revenue of $2.0B (-1.8%) in-line. (PR) (~from Mon. evening)
  Comment!

• Monday, April 20, 2009

• 15:10 PM Notable earnings after Monday's close: BRO, BSX, BXS, CNI, IBM, PKG, SYK, TXN, ZION 1 Comment
• 00:10 AM Notable earnings after Monday's close: BRO, BSX, BXS, CNI, IBM, PKG, SYK, TXN, ZION Comment!